[1] [1] D. C. P. Cobben et al., “New diagnostic techniques in staging in the surgical treatment of cutaneous malignant melanoma," Eur. J. Surg. Oncol. 28, 692–700 (2002).

[2] [2] W. Liu et al., “Rate of growth in melanomas: Characteristics and associations of rapidly growing melanomas," Arch. Dermatol. 142, 1551–1558 (2006).

[3] [3] I. Helfrich et al., “Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma," J. Exp. Med. 207, 491–503 (2010), doi: 10.1084/jem.20091846.

[4] [4] J. Folkman, “The role of angiogenesis in tumor growth," Seminar. Oncol. 29, 15–18 (2002).

[5] [5] W. Lu, A. J. Schroit, “Vascularization of melanoma by mobilization and remodeling of preexisting latent vessels to patency," Cancer Res. 65, 913 (2005).

[6] [6] W. W. Choi et al., “Angiogenic and lymphangiogenic microvessel density in breast carcinoma: Correlation with clinicopathologic parameters and VEGF-family gene expression," Mod. Pathol. 18, 143–152 (2005), doi: 10.1038/modpathol.3800253.

[7] [7] P. Salven et al., “Endothelial Tie growth factor receptor provides antigenic marker for assessment of breast cancer angiogenesis," Br. J. Cancer 74, 69–72 (1996).

[8] [8] J. D. Shields et al., “Lymphatic density and metastatic spread in human malignant melanoma," Br. J. Cancer 90, 693–700 (2004).

[9] [9] L. R. Berry et al., “Quantification of viable tumor microvascular characteristics by multispectral analysis," Magn. Resonance Med. 60, 64–72 (2010).

[10] [10] Y. Gazit et al., “Fractal characteristics of tumor vascular architecture during tumor growth and regression," Microcirculation 4, 395–402 (2015).

[11] [11] J. Bowling et al., “Dermoscopy key points: Recommendations from the international dermoscopy society," Dermatology 214, 3–5 (2007), doi: 10.1159/000096904.

[12] [12] I. Tromme et al., “Selective use of sequential digital dermoscopy imaging allows a cost reduction in the melanoma detection process: A belgian study of patients with a single or a small number of atypical nevi," Plos One 9, e109339 (2014).

[13] [13] S. A. Rstom, L. S. Liborio, F. M. Paschoal, “Re°ectance confocal microscopy of cutaneous melanoma. Correlation with dermoscopy and histopathology," An. Bras. Dermatol. 90, 411–414 (2015), doi: 10.1590/abd1806-4841.20153774.

[14] [14] T. T. Kien, “Biopsy of the pigmented lesion–when and how," J. Am. Acad. Dermatol. 5 (2008).

[15] [15] A. F. Fercher, W. Drexler, C. K. Hitzenberger, T. Lasser, Conf. Lasers Electro-Optics.

[16] [16] J. G. Fujimoto, C. Pitris, S. A. Boppart, M. E. Brezinski, Optical coherence tomography: An emerging technology for biomedical imaging and optical biopsy 1," Neoplasia 2, 9–25 (2000).

[17] [17] B. E. Bouma, G. J. Tearney, “Clinical imaging with optical coherence tomography H," Acad. Radiol. 9, 942–953 (2002).

[18] [18] J. G. Fujimoto et al., “Optical biopsy and imaging using optical coherence tomography," Nat. Med. 1, 970–972 (1995).

[19] [19] W. Drexler et al., Bios 99 Int. Biomed. Opt. Symp. 20. M. A. Boone, S. Norrenberg, G. B. Jemec, V. Del Marmol, “High-definition optical coherence tomography imaging of melanocytic lesions: A pilot study," Arch. Dermatol. Res. 306, 11–26 (2014), doi: 10.1007/s00403-013-1387-9.

[20] [20] Z. Guo et al., “Monitoring skin photodamage using quantitative optical coherence tomography," Spienewsroom (2011).

[21] [21] A. H. Skalet et al., “Optical coherence tomography angiography characteristics of iris melanocytic tumors," Ophthalmology 124, 197–204 (2017).

[22] [22] C. W. Jr, L. From, E. A. Bernardino, M. C. Mihm, “The histogenesis and biologic behavior of primary human malignant melanomas of the skin," Cancer Res. 29, 705–727 (1969).

[23] [23] B. R. Smoller, “Histologic criteria for diagnosing primary cutaneous malignant melanoma," Mod. Pathol. 19(2), S34–S40 (2006), doi: 10.1038/modpathol.3800508.

[24] [24] T. B. Porcia, “Acral lentiginous melanoma: Incidence and survival patterns in the United States, 1986–2005," Arch. Dermatol. 4 (2009).

[25] [25] M. G., “MicroRNAs in the pathogenesis of malignant melanoma," J. Eur. Acad. Dermatol. Venereol. 2 (2013).

[27] [27] G. A. V. Tilborg et al., “Improved magnetic resonance molecular imaging of tumor angiogenesis by avidin-induced clearance of nonbound bimodal liposomes," Neoplasia 10, 1459–1469 (2008).

[28] [28] S. Naito, A. C. von Eschenbach, R. Giavazzi, I. J. Fidler, “Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice," Cancer Res. 46, 4109 (1986).

[29] [29] J. M. M. Perez, J. Pascau, Image Process. Image J. (2016).

[30] [30] C. A. Schneider, W. S. Rasband, K. W. Eliceiri, “NIH Image to ImageJ: 25 years of image analysis," Nat. Meth. 9, 671–675 (2012).

[31] [31] E. Seifert, “OriginPro 9.1: Scientific data analysis and graphing software-software review," J. Chem. Inf. Model. 54, 1552 (2014).

[32] [32] M. Mogensen, L. Thrane, T. M. Joergensen, P. E. Andersen, G. B. Jemec, “Optical coherence tomography for imaging of skin and skin diseases," Semin. Cutan. Med. Surg. 28, 196–202 (2009), doi: 10.1016/j.sder.2009.07.002.

[33] [33] A. Field, Discovering Statistics Using IBM SPSS Statistics. (2013).

[34] [34] T. Gambichler et al., “Characterization of benign and malignant melanocytic skin lesions using optical coherence tomography in vivo," J. Am. Acad. Dermatol. 57, 629–637 (2007), doi: 10.1016/j.jaad.2007.05.029.

[35] [35] J. K. Barton et al., “Investigating sun-damaged skin and actinic keratosis with optical coherence tomography: A pilot study," Technol. Cancer Res. Treat 2, 525–535 (2003).

[36] [36] B. Hans-Jürgen, M. Andreas, K. Jürgen, K. L. Gerhard, “Optical coherence tomography versus ultrasound biomicroscopy of conjunctival and eyelid lesions," Klinische Monatsbltter F€ur Augenheilkunde 220, 822–829 (2003).

[37] [37] J. Strasswimmer, M. C. Pierce, B. H. Park, V. Neel, J. F. D. Boer, “Polarization-sensitive optical coherence tomography of invasive basal cell carcinoma," J. Biomed. Opt. 9, 292 (2004).

[38] [38] W. Tjalma et al., “Quantification and prognostic relevance of angiogenic parameters in invasive cervical cancer," Br. J. Cancer 78, 170 (1998).